Inclusion Body Myositis Treated with Alemtuzumab
Inclusion body myositis (IBM) is a chronic inflammatory myopathy with a progressive course. It is more common in the later years of life and usually presents with limb weakness. We present the case of a patient who developed proximal weakness in the lower limbs and, four years later, facial asymmetr...
Main Authors: | Juliana Sá, João Costelha, Antonio Marinho |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2019-12-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1368 |
Similar Items
-
Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01) -
Diagnostic Value of Muscle [11C] PIB-PET in Inclusion Body Myositis
by: Yu-ichi Noto, et al.
Published: (2020-01-01) -
Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
by: Boel De Paepe
Published: (2019-01-01) -
Mitochondrial Biology in Sporadic Inclusion Body Myositis
by: Shabrokh, Elika
Published: (2014) -
Inclusion body myositis — a case based clinicopathological update
by: Bodoki Levente, et al.
Published: (2014-02-01)